-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $4.5

Benzinga·03/03/2025 12:34:16
Listen to the news
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $4.2 to $4.5.